Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Depreciation & Amortization (CF) (2019 - 2025)

Historic Depreciation & Amortization (CF) for AdaptHealth (AHCO) over the last 7 years, with Q3 2025 value amounting to $97.7 million.

  • AdaptHealth's Depreciation & Amortization (CF) rose 766.54% to $97.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $375.0 million, marking a year-over-year increase of 212.36%. This contributed to the annual value of $365.3 million for FY2024, which is 455.85% down from last year.
  • Per AdaptHealth's latest filing, its Depreciation & Amortization (CF) stood at $97.7 million for Q3 2025, which was up 766.54% from $92.4 million recorded in Q2 2025.
  • Over the past 5 years, AdaptHealth's Depreciation & Amortization (CF) peaked at $102.3 million during Q4 2022, and registered a low of $47.2 million during Q1 2021.
  • Over the past 5 years, AdaptHealth's median Depreciation & Amortization (CF) value was $92.3 million (recorded in 2022), while the average stood at $86.4 million.
  • As far as peak fluctuations go, AdaptHealth's Depreciation & Amortization (CF) soared by 26403.32% in 2021, and later tumbled by 975.05% in 2023.
  • AdaptHealth's Depreciation & Amortization (CF) (Quarter) stood at $77.2 million in 2021, then soared by 32.52% to $102.3 million in 2022, then dropped by 9.75% to $92.4 million in 2023, then fell by 1.98% to $90.5 million in 2024, then increased by 7.93% to $97.7 million in 2025.
  • Its Depreciation & Amortization (CF) was $97.7 million in Q3 2025, compared to $92.4 million in Q2 2025 and $94.3 million in Q1 2025.